NASB Financial, Inc. Announces Redemption of Trust Preferred Securities
NASB Financial, Inc. Announces Redemption of Trust Preferred Securities
PR Newswire
KANSAS CITY, Mo., April 1, 2024
KANSAS CITY, Mo., April 1, 2024 /PRNewswire/ -- NASB Financial, Inc. (OTCQX: NASB) (the "Company") announced today that NASB Preferred Trust I (the" Trust"), a subsidiary trust of the Company, is redeeming $25 million of outstanding trust preferred securities ("TRUPS"), which constitute all outstanding TRUPS issued by the Trust. The securities are being redeemed on April 30, 2024, at the contractual call price of 100% plus any accrued interest payable through the redemption date. All related junior subordinated debentures issued by the Company to the Trust will be repaid as part of the redemption transaction.
NASB Financial, Inc. is a unitary thrift holding company for North American Savings Bank, F.S.B. ("NASB"). Since 1927, NASB has been serving the financial needs of customers by providing an array of personal banking and lending products in the Kansas City metro area. NASB offers competitive residential and commercial mortgages nationwide with the safety and security of a Federal institution. For more information, visit nasb.com.
SOURCE NASB Financial, Inc.
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track